Brincidofovir

布林西多福韦

Report date: 2026/05/23 20:00:57

Base Information

Drug NameBrincidofovir
Drug Alias Name布西多福韦BCVCidofovir PIM conjugateHexadecyloxypropyl-cidofovirCidofovir hexadecyloxypropyl ester +[16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitors
TargetsVirus DNA polymerase
Therapy Area/IndicationsRejection of renal transplantationBK Polyomavirus InfectionsKidney Diseases +[15
Global Approved IndicationsSmallpox
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/06/04
Country/TerritoryBelgiumCanadaUnited States +[15
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsGlioblastomaSmallpoxCytomegalovirus Infections +[5
Inactive IndicationsRejection of renal transplantationBK Polyomavirus InfectionsKidney Diseases +[10

Other Information

ATC CodeJ05A
Related LinksWikipediaKEGG